Acumen Pharmaceuticals

Acumen Pharmaceuticals

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$1.21-$3.60
Market Cap
$216.2M
Shares Short
3M

Financials

See more
Revenue (12 Mos)
$329,000
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
-$86.7M
Diluted EPS
-$1.59

News

See more

Yahoo Finance • last month

VERAXA Biotech Shows Regulatory Progress on Cancer Therapy Platform

Yahoo Finance • last month

Slate Medicines Appoints Mark W. Hahn to Board of Directors

Yahoo Finance • last month

Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ (EBD™) Program Data and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026

Yahoo Finance • 2 months ago

Acumen Pharmaceuticals to Present Data on Enhanced Brain Delivery™ (EBD™) Technology and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026

About

CEO
Mr. Daniel J. O'Connell M.B.A.
CFO
Mr. Matt Zuga
Address
1210-1220 Washington St., Newton, MA, United States, 02465
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
60